At least 10 billion vaccines need to be distributed to defeat the coronavirus pandemic on a global scale.
Drug companies say it is impossible to provide the vaccine on a global scale, Qadin.Net reports citing publika.az.
German logistics company Deutsche Post says Moderna, Pfizer and CureVac, which are on the list of promising vaccines, need to be cooled to minus 80 degrees Celsius and can be delivered to two-thirds of the world's population. According to the company, the supply of vaccines to Africa, South America and some parts of Asia, which has a limited source of electricity, covering two-thirds of the world's population, is a very difficult task.
Currently, five of the vaccines that can be distributed around the world are being tested on humans and are among the most promising in this field. However, providing the necessary technology to supply these vaccines, which are important to maintain at Antarctic surface temperatures, requires a large budget.
A study by Deutsche Post in conjunction with McKinsey found that cold air depot infrastructure was deteriorating in regions other than the 25 most developed countries, home to a third of the world's population.
However, the US companies Moderna and Translate Bio announced in June that they were investigating the transport and storage of potential vaccines at lower temperatures.
CureVac claims that an experimental rabies vaccine can be stored in a standard refrigerator for months and still retains its molecular structure, and that tests have been conducted to show that the COVID-19 vaccine has the same resistance.
The Deutsche Post warns that in this case, a significant part of the African continent may not have access to vaccines.
NEWS TAPE
